Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
To demonstrate the efficacy of LCZ696 in patients with chronic heart failure with preserved ejection fraction (HF-PEF) by testing the hypothesis that the reduction in NT-proBNP from baseline to study end with LCZ696 is greater than that with valsartan after 12-weeks of treatment
Inclusion criteria
- Chronic Heart Failure